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The Effect of an Intravitreal Triamcinolone Acetonide Injection 
for Acute Nonarteritic Anterior Ischemic Optic Neuropathy
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The purpose of this case report is to evaluate the visual outcome of an intravitreal triamcinolone acetonide 
injection (IVTA) as a treatment for a patient with acute nonarteritic anterior ischemic optic neuropathy (NAION). A 
65-year-old male patient with severe visual loss due to acute NAION was treated with 4 mg/0.1mL IVTA. Fundus 
examination and measurements of the patient’s best-corrected visual acuity and visual field were performed 
before and after the injection at 2 weeks, 1 month, 3 months, and 6 months. The best-corrected visual acuity 
changed from 0.05 before the injection to 0.16 at 2 weeks, 0.3 at 1 month, and 0.4 at 3 months and at the final visit. 
Optic disc swelling had markedly decreased at 1 week postoperatively and disappeared at 2 weeks after the 
injection. The clinical course of this patient suggests that an IVTA may be effective in increasing visual acuity 
following an acute NAION. A large randomized controlled trial is needed to assess the efficacy of IVTA as a 
treatment for NAION.
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Fig. 1. A fundus photograph at the time of diagnosis demonstrates optic 
disc swelling with a flame-shaped hemorrhage. The optic disc swelling 
involved the whole disc, with the exception of the superior zone.
Nonarteritic anterior ischemic optic neuropathy (NAION) 
is characterized by a sudden, painless, monocular visual loss 
in patients after the fourth or fifth decade of life.
1,2 The known 
risk factors are a small optic nerve head, systemic hypertension, 
and hyperlipidemia.
3,4 However, there is no proven effective 
treatment for NAION patients.
2,5
Intravitreal triamcinolone acetonide injection (IVTA) may 
help to resolve optic disc edema and stop a vicious cycle of 
ischemia and edema which can lead to further tissue infarction.
6 
Recently, Jonas et al.
7 reported that IVTA was not effective 
treatment for NAION; however, Kaderli et al.
6 reported rapid 
visual recovery following IVTA in NAION patients.
The purpose of this study is to report the visual outcome of 
a single patient who received 4 mg IVTA as treatment for 
acute NAION.
Case report
A 65-year-old male presented with sudden visual loss of 
his right eye of 4 days duration. The patient noted his visual 
loss upon awakening from sleep. There was no associated 
ocular pain or headache. His initial best-corrected visual 
acuity was 0.05 and a relative afferent pupillary defect (1.8 
log unit) was present. Fundus examination of his affected eye 
demonstrated optic disc edema and a flame-shaped peripapillary 
hemorrhage (Fig. 1). The optic disc edema involved the whole Korean J Ophthalmol Vol.23, No.1, 2009
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Fig. 2. Intravenous fluorescein angiogram. The early phase of an in-
travenous fluorescein angiogram showed a segmental perfusion de-
lay in the optic disc.
Fig. 3. Visual field plotted by Goldmann perimeter at the time of 
diagnosis. A diffuse cecocentral scotoma was observed.
Fig. 4. A fundus photograph at 3 months after the IVTA injection 
demonstrates a segmental pale neuroretinal rim (5 o’clock-11 
o’clock) which corresponds with the previous segmental perfu-
sion delay seen with the fluorescein angiogram.
disc, with the exception of the superior zone. The early phase 
of an intravenous fluorescein angiogram showed a segmental 
perfusion delay of the optic disc (Fig. 2). A diffuse cecocentral 
scotoma was present in the right eye (Fig. 3). The patient reported 
a history of systemic hypertension of at least 10 years. The 
erythrocyte sedimentation rate, C-reactive protein levels, and 
protein C concentration were all normal. The patient did not 
show any characteristics of arteritic anterior ischemic optic 
neuropathy and was diagnosed with acute NAION. The patient 
was informed of the natural history of NAION and the fact 
that there is no proven effective treatment for NAION. After 
full explanation of the expected effects and possible compli-
cations of IVTA, the patient provided informed consent.
An intravitreal injection of 4 mg/0.1mL triamcinolone 
acetonide (TA) was performed in the affected eye. The IVTA 
injection was performed in a surgical room under sterile 
conditions with topical anesthesia (Alcaine
®, Alcon, USA). The 
injection was administered with a 30 gauge needle, 4.0 mm 
from the inferotemporal limbus. To prevent infection and 
ocular hypertension due to the IVTA, the patient received 
topical antibiotics (Vigamox
®, Alcon, USA) following the 
injection and his intraocular pressure was measured 24 hours 
after the IVTA injection and at each follow-up visit. Measure-
ments of the patient’s best-corrected visual acuity by Snellen 
acuity, Goldmann perimetry, applanation tonometry, slit lamp 
biomicroscopy, and fundus examination of the affected eye 
were performed at 2 weeks, 1 month, 3 months, and 6 months 
following the IVTA.
The patient’s best-corrected visual acuity changed from 
0.05 before the injection to 0.16 at 2 weeks, 0.3 at 1 month, 
and 0.4 at 3 months postoperatively and at the final visit. The 
optic disc edema had markedly decreased at 1 week and 
disappeared at 2 weeks following the injection. At 3 months 
after the IVTA injection, we observed a segmental pale neuro-
retinal rim (5 o’clock-11 o’clock) during the fundus exam 
(Fig. 4). The area of the pale neuroretinal rim corresponded 
with the previous segmental perfusion delay seen with the 
fluorescein angiogram. The patient did not develop intraocular 
pressure exceeding 21 mmHg, progression of cataract, or 
endophthalmitis during follow-up.
Discussion
The patient presented here showed a relatively good recovery 
of visual acuity and a rapid resolution of optic disc edema. 
The patient’s best-corrected visual acuity improved by five BJ Sohn, et al. IVTA FOR ACUTE NONARTERITIC AION 
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Snellen lines following the IVTA injection. There was also a 
marked decrease in optic disc edema during the first week 
after the injection and resolution of the optic disc edema by 
the second week.
The natural course of optic disc edema in NAION has been 
reported to spontaneously resolve within 6-8 weeks.
2,8 We 
suggest that rapid resolution of the optic disc edema in this 
patient may be the major cause of visual acuity recovery. It 
has been inferred that rapid reduction of optic disc edema by 
IVTA could prevent further tissue damage by stopping a vicious 
cycle of ischemia, edema, and compartment syndrome occurring 
in NAION.
2,6 Another possibility may be that IVTA could serve 
to decrease macrophage presence in the affected areas of 
infarcted brain and optic nerve;
9 however, we do not have 
any histological proof of this hypothesis.
The result of the present study corresponds with Karderli 
et al.
6 who reported that IVTA led to recovery of visual acuity 
in 4 NAION patients. However, our finding is different from 
those of Jonas et al.,
7 who reported that IVTA was not effective 
in visual acuity recovery for 3 NAION patients. The reason 
for this difference is the dosage of TA used. Twenty mg of TA 
is 5 times greater than the 4 mg used in our study and by 
Karderli et al.
6; a higher dose of TA remains in the eye longer. 
One of the patients in the study by Jonas et al.
7 developed 
ocular hypertension following IVTA injection. A high intra-
ocular pressure might interfere with vascular circulation and 
axoplasmic transport in the affected eye. In addition, they did 
not mention the duration of optic disc edema following the 
IVTA injection.
This is the first case report that demonstrates visual acuity 
recovery in acute NAION following IVTA injection in a 
Korean patient. Considering that there is no proven effective 
treatment for NAION, IVTA injection could be an alternative 
and effective treatment option for acute NAION without any 
systemic complications. However, large randomized controlled 
trials may be necessary to establish the efficacy and safety of 
IVTA injections as the treatment of choice for acute NAION.
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